Intracranial dural arteriovenous fistulas (DAVFs) are abnormal arteriovenous communications within the dura locating near a major venous sinus and are supplied by pachymeningeal arteries. DAVFs represent 10e15% of all intracranial arteriovenous malformations. The natural history and clinical manifestations are determined by location of the DAVFs and their angioarchitecture. Aggressive DAVF is usually associated with leptomeningeal venous drains or reflux. It may present with hemorrhagic or nonhemorrhagic stroke. The goal of embolization of DAVFs is total fistula occlusion without interfering with the normal duraevenous drains. Embolization can be performed by transarterial and/or transvenous routes or direct puncture of affected dural sinus. Selection of embolic materials depends on access route and angioarchitecture of the fistula. With the involution of endovascular devices, embolic materials, and high-quality angiography, endovascular embolization of DAVFs has been proved a safe and effective method of treating these complex cerebrovascular lesions.
Introduction
Dural arteriovenous fistulas (DAVFs) can occur in any intracranial dural regions, most commonly in the cavernous sinus or transverse-sigmoid sinus.
1e3 DAVFs are usually fed by dural branches of the external carotid artery. The etiology of DAVFs is not fully understood; some are congenital and others are acquired, but most are thought to be acquired. Different etiologies have been implicated including thrombosis, trauma, or surgery or in the postpartum period.
4e6 Patients may be asymptomatic or may experience symptoms ranging from mild symptoms to fatal hemorrhage.
7e11 DAVFs have been classified to benign type with dural sinus drain or aggressive type with leptomeningeal venous drain and/or reflux which may associate with hemorrhage or nonhemorrhagic neurologic deficits.
12e14 Management of DAVFs includes open surgery, radiosurgery, embolization, or combined treatment. In this article, we will discuss the method of embolization, with emphasis on the access routes, embolic materials, and individual DAVF embolization.
Symptoms, natural history, and classification of intracranial DAVFs
The clinical presentations of DAVF are variable, depending on the location of the shunt and angioarchitecture of the shunting flow. These symptoms include exophthalmos, bruit, cranial nerve deficits, tinnitus, hemorrhagic or nonhemorrhagic neurological deficits, increased intracranial pressure, papilledema, and cerebrospinal fluid reabsorption abnormalities resulting in ventricular enlargement or congestive heart failure. Several classification systems have been developed to grade the risks and natural course of DAVFs.
Those devised by Cognard et al 15 and Borden et al 16 are the most widely used. All these classifications emphasize the fistula venous drains. DAVFs with antegrade dural sinus drains and only association with sinus reflux usually present with benign symptoms. By contrast, DAVFs with retrograde leptomeningeal cortical venous drainage channel show a significantly high rate of aggressive symptoms such as hemorrhagic and nonhemorrhagic neurologic clinical manifestation. Although DAVF location is not directly correlated with aggressive behavior, the propensity for dangerous drainage patterns found at initial diagnosis does vary with location.
Goal of embolization of DAVFs
The treatment strategy of DAVFs should be tailored individually to patients considering the angioarchitecture, natural history of the DAVFs, and the severity of symptoms. The definitive treatment of DAVFs requires the occlusion of the arteriovenous shunt without interfering with the normal venous drains. Treatment can be performed by conventional open neurosurgery, radiosurgery, or endovascular embolization, or a combination of these modalities. The first reported series of embolization cases was by Halbach et al in the 1980s. 17 With the development of newer techniques and embolic materials in the field of interventional neuroradiology, endovascular therapy has now been developing as the primary treatment strategy to manage DAVFs, particularly in high-risk DAVFs, reserving surgery only if endovascular techniques fail or are unfeasible. The goal of embolization is to achieve an angiographic cure by obliteration of all feeders and proximal draining veins with preservation of the patency of the affected sinus. In those difficult and complex DAVFs with a difficulty of achieving total occlusion of the fistula, the goal of embolization is to achieve partial treatment with reversal of the aggressive type of DAVF to benign type, to facilitate subsequent radiosurgery or neurosurgery.
18e20 Embolization should usually fulfill the following requirements. If a sinus is occluded or severely stenosed, treatment should be directed to reestablish sinus patency 21, 22 ; if that fails, sinus occlusion with angiographic cure of DAVF is considered. If there is a functional venous pathway that was not previously occluded, it should not be sacrificed. Treatment should not induce redirection of flow to other cortical veins. that the microcatheter be positioned into the ideal distal aspect of the feeding artery, with delivery of the embolic material through a feeding artery to the shunt and then into the most proximal venous outlet. Although some studies have shown good outcome with low complication rates for occluding DAVFs via a transarterial route using liquid embolic agents, 23e26 this route may not always be feasible, because of multiple, small, and tortuous feeders. Furthermore, some risks may occur by inadvertent embolization of carotid or vertebral territory with ischemic stroke via dangerous anastomosis of the externaleinternal carotid artery or vertebral artery anastomoses or embolization of feeders of cranial nerves. In addition, proximal occlusion of feeding artery allows the persistent arterial flow and recruitment of collateral blood supply; therefore recurrence is likely. Furthermore, embolic material migration to the venous site may result in venous occlusion exacerbating venous hypertension. In the past, to achieve an angiographic cure with complete fistula occlusion, TVE with coil packing of the affected dural sinus was selected. This technique is logical as long as the diseased segment of the sinus is occluded completely or does not participate in normal venous return. However, TVE is not always feasible in cases with difficult fistula anatomy, such as in isolated or high-grade stenotic dural sinus. Embolization of DAVFs by direct puncture of affected sinus via transorbital (e.g., cavernous sinus) 27e29 or via craniotomy (e.g., lateral, superior sagittal sinus, or sinus confluence) 30e32 has been reported, with promising results. The advantages of transcraniectomy access are ease of fistula access after direct surgical exposure, ease of direct sinus coil packing in a small craniectomy, and ability to performed embolization without any intradural surgical manipulation. The disadvantage of this access route is the potential complication of craniectomy, including blood loss or infection. Generally, the affected sinus should be in a superficial location close to the cranium, isolated, and near another sinus. Direct puncture to access the affected sinus is an alternative. Because of the procedure's inherent invasiveness, it has only been considered when endovascular routes fail based on angioarchitecture analysis. In some complex DAVFs, a combination of TAE and TVE is considered.
Embolization access routes

Selection of embolic materials
Different embolic materials have been used. These include n-butyl-2-cyanoacrylate (NBCA; Codman, Raynham, MA, USA), particles (polyvinyl alcohol; PVA), Onyx (eV3; Neurovascular Inc., Irvine, CA, USA) or detachable coils. Coils usually are selected for transvenous occlusion of an affected nonfunctional dural sinus. TAE with PVA usually does not produce a durable cure, therefore, it can only be used as a supplement to eliminate residual minimal flow after embolization, to induce thrombosis of residual fistula, or for palliative management of benign DAVFs. NBCA is a cheap, fast embolic material. Prior to the advent of Onyx, NBCA was widely used to occlude DAVFs transarterially.
33e36 Because NBCA is a liquid adhesive, this procedure requires a highly experienced operator with the ability to determine the appropriate concentration of NBCA (about 20e25%). The major disadvantages of NBCA are short injection time (within minutes) and limited amount of NBCA mixture injection leading to insufficient embolization and lower cure rate (30e50%). 34e36 The angiographic occlusion rate is statistically higher with Onyx compared with NBCA. 33 Another concern is that it is difficult to control NBCA flow after injection, resulting in proximal arterial occlusion in highly concentrated NBCA or migration to a draining vein, resulting in a risk of venous infarction or hemorrhage in low-concentrated NBCA. Onyx, a nonadhesive liquid embolic system, consists of ethylene vinyl alcohol as the embolic material, dimethyl sulfoxide as the solvent to deliver ethylene vinyl alcohol, and tantalum powder for radiographic visualization. Onyx was initially introduced in 1999 to treat brain arteriovenous malformation. In 2006, the first case of a DAVF successfully occluded by Onyx was reported. 24 Subsequently, other case reports and case series were published. 25, 26, 37, 38 Onyx provides advantages by the ability to perform a slow, controlled injection. Injection of larger amounts of Onyx can result in filling of the fistulous network and allow for reflux into other arterial feeders in a single feeder embolization. The development of Onyx was a milestone in the endovascular treatment of DAVF, with promising results with a relatively high morphologic cure rate of 62.5e80%. 25, 26, 37, 38 However, there are some disadvantages of Onyx. The long-term patency of Onyx embolization is unknown. Onyx itself may leave microchannels within the cast that allow a small fistula of flow, resulting in recurrence after endovascular embolization. In addition, Onyx has been thought to cause significant inflammation within the vasculature, particularly with treatment of cavernous carotid fistulas in which the surrounding cranial nerves are often irritated, resulting in various cranial nerve palsies.
Embolization of individual DAVFs
Transverseesigmoid sinus DAVFs
The transverseesigmoid sinus (TSS) represents the most common location for DAVFs. Spontaneous regression of TSS DAVFs is uncommon and usually occurs following hemorrhagic events. 39 The arterial supply originates from the dural branches of the occipital artery, middle meningeal artery, ascending pharyngeal artery, and/or dural branches of the vertebral artery or tentorial branches of the meningohypophyseal trunk. Although their most common symptoms are benign (e.g., pulsatile tinnitus and headache), TSS DAVFs may present with hemorrhagic and nonhemorrhagic aggressive neurologic symptoms. All TSS DAVFs are considered to require treatment because of the low rate of spontaneous regression without symptomatic events and the relatively high rate of aggressive symptoms. The selection of endovascular management of TSS DAVFs depends on the patient's symptoms and angioarchitecture analysis. If patients present with benign DAVFs with functional antegrade TSS drainage, TAE with preservation of the patency of the TSS and symptomatic treatment is the first choice. In those aggressive TSS DAVFs with leptomeningeal venous drainage/ reflux, the goal of treatment is total occlusion of the DAVFs by TAE or TVE. Transvenous coil packing of the affected TSS is usually safe and highly effective if the affected sinus does not participate in normal TSS venous return. Angiographic cure can be achieved in 80e100% of patients. 39e41 This procedure requires sacrifice of sinus flow, therefore, occlusion of the nearby normal antegrade cortical venous drainage should be avoided. The rate of permanent complications is approximately 4%. Transarterial access by liquid embolic materials is selected for those patients with functionally affected TSS or failure to access by transvenous route. The reported cure rate for using TAE with NBCA is approximately 60%. 1 Recently, TAE with ONYN has replaced the NBCA as the first choice of liquid embolic material because of better morphologic cure. The cure rate may be up to 100% in some selected patients. 42 Another option for managing TSS DAVFs with high-grade stenosis or occlusion is endovascular stent placement. Recanalization, angioplasty, and stenting of stenosis/occlusive TSS can restore antegrade sinus flow and close shunts within the sinus wall, however, only a few successful cases have been reported. 21, 22 Further investigation of the effectiveness of stent placement in the treatment of DAVFs is necessary.
Cavernous sinus DAVFs
Cavernous sinus (CS) DAVF represents the second most common location for DAVFs; it usually occurs in middle-aged women and is fed by multiple small dural branches of the internal and/or external carotid arteries. Because of their slowflow shunts, some CS DAVFs have a tendency to undergo spontaneous thrombosis, observed in 10e50% of cases. 43 Regarding management of CS DAVFs, if patients present with mild clinical symptoms with no angiographic risk of hemorrhagic or nonhemorrhagic neurologic deficits, conservative treatment, or a less invasive procedure such as observation, manual compression of the carotid artery, 44 or radiosurgery 45 can be applied. If patients have pial reflux and/ or are at risk of clinical deterioration such as gradual loss of visual acuity or cranial nerve palsy, embolization is required. The most common symptoms of CS DAVFs AVF are ocular symptoms (e.g., chemosis, exophthalmos) caused by anterior venous drainage; posterior drainage to inferior or superior petrous sinus may lead to bruit or cranial nerve palsy or reflux to cerebellar veins; superior drainage to superficial middle cerebral vein may occasionally have a risk of impairment of local cerebral venous drain. Aggressive neurologic symptoms such as intracranial hemorrhage are extremely rare; inferior drains to the pterygoid plexus may lead to bruit or nasal congestion. Transvenous coil packing of affected CS has been proved to be an effective and safe method to manage the CS DAVF. The cure rate varied from 80% to 100%. 46 However, dense packing of the CS with coils should be avoided because of the risk of cranial nerve deficits due to coil compression. There are many transvenous routes to reach the CS, and these include the inferior petrous sinus, basilar plexus, facial vein, angular vein, and superior ophthalmic vein, or through the pterygoid plexus. Recently, TAE with Onyx of CSDAVFs has been performed, with better morphologic outcomes than those treated by NBCA. However, embolization via the middle meningeal artery with occlusion of blood flow to facial or trigeminal nerve has been reported. Another concern is the migration of Onyx cast to the pial artery via dangerous anastomoses leading to ischemic stroke and/or blindness. On rare occasions with aggressive CS DAVF, in which there is failure to access via the endovascular route, a transorbital approach is an alternative. Successful treatment of geometrically difficult CS DAVF by transorbital direct puncture of the ophthalmic vein or anterior CS under fluoroscopic guidance has been reported. 28e30 The potential risks of these procedures include orbital hemorrhage, injury to the optic nerve or other cranial nerves in the CS, globe puncture, and infection. Therefore, the operator should be familiar with orbital anatomy and equipped with high-quality digital subtraction angiography.
Tentorial DAVFs
Tentorial DAVFs represent 4e8% of all intracranial fistulas. 1, 47, 48 Because tentorial DAVFs drain only via the leptomeningeal vein, they carry a high risk of aggressive neurologic symptoms. The reported aggressive clinical behavior in 79e92% of cases, 12, 16, 48 the occurrence of intracranial hemorrhage is about 70% 14 ; in some cases, this hemorrhage consists of fatal bleeding in the posterior fossa. The arterial supply mainly comes from the tentorial artery, such as dural branches of the meningohypophyseal trunk and/or middle meningeal artery. Venous drainage is usually through the superior petrosal sinus or through the pontine, perimesencephalic, and basal veins into the Galenic system. Because of the aggressive behavior of tentorial DAVFs, the goal of embolization is total fistula occlusion. In the past, TAE was effective by using NBCA occlusion of the proximal draining vein, whereas TVE with coils was preferred when the lesion was anatomically suited. 48 Now, TAE with deposition of liquid embolic material such as NBCA or Onyx to occlude the fistula is commonly selected. The angiographic cure rate by TAE with Onyx is better than that for treatments with NBCA. Huang et al 49 reported 12 patients presenting with intracranial hemorrhage who were treated by Onyx embolization. Complete cure was achieved in 11 patients. All of the patients recovered well, except one who died of severe infection caused by ventricular drainage.
Superior sagittal sinus DAVFs
Superior sagittal sinus (SSS) DAVFs represent approximately 3e8% of all intracranial DAVFs. 1, 15 They are frequently associated with restrictive drainage of the SSS and retrograde cortical venous drainage, therefore, aggressive neurologic symptoms are seen in 50% of cases. The reported bleeding rate of SSS DAVFs is about 15e40%. 1, 15, 50 Venous congestion and ischemia of the bilateral frontal lobes due to SSS DAVFs can cause dementia. These fistulas are usually supplied by dural branches of bilateral middle meningeal arteries and/or the anterior falcine artery from the ophthalmic arteries. Therefore, SSS DAVFs commonly possess multiplicity in arterial feeders and critical venous drainage. Endovascular management of SSS DAVFs is similar to that for treating TSS DAVFs. However, SSS DAVFs are more frequently associated with hemorrhagic and nonhemorrhagic stroke and therefore often require aggressive treatment. TVE with coil packing of affected SSS is the first choice if the SSS is not functional for normal cortical vein drainage. Nevertheless, SSS DAVFs are usually associated with SSS occlusion or stenosis; the TVE is often difficult. In cases with difficult access via the transvenous route, or if the SSS has participated in normal venous drainage, TAE with NBCA or Onyx is indicated; however, the feeders of meningeal arteries are usually distally and tortuously located, leading to difficulty in navigating the microcatheter to the fistula site. TAE with occlusion of feeding arteries is commonly associated with insufficient embolization, with fistula recurrence by recruitment of the feeders. In the past, TAE using NBCA was selected to achieve angiographic cure or as an adjunct therapy for subsequent radiosurgery or open surgery. Recently, NBCA was replaced by Onyx as a transarterial embolizer because of better angiographic and clinical outcomes. Chai et al 51 reported four cases in which successful angiographic cure was achieved with Onyx via TAE.
Anterior cranial fossa DAVFs
Anterior cranial fossa DAVFs constitute rare lesions, representing < 10% of all DAVFs. 52 DAVFs located on the anterior fossa drain through the retrograde leptomeningealecortical venous drainage system only, associating with a high risk of hemorrhagic or nonhemorrhagic aggressive symptoms. The occurrence of intradural hemorrhage is about 84% 15 ; therefore, a complete angiographic cure is necessary. The arterial supply is mainly from the posterior and anterior ethmoidal branches of the ophthalmic arteries. They may also recruit supply from the ethmoidal branches of the external carotid artery. Because there is no dural sinus in this area, the main venous drainage is into the frontal cortical veins and secondarily into the SSS. In the past, this type of fistula was considered as difficult for endovascular treatment, as the supplying vessels are small and tortuous, precluding catheterization with current technology. By contrast, surgical approaches are relatively easy and safe. When TAE with selective catheterization through the ophthalmic artery is performed, it is paramount to verify that the microcatheter tip is located beyond the origin of the central retina artery to avoid complications such as stroke and blindness. Few anterior fossa DAVFs can be safely treated with TVE, because transvenous routes are also tortuous and often associated with venous aneurysms. However, this approach is more complicated and rarely used when treating this type of DAVF. Some authors strongly oppose embolization as it poses numerous technical difficulties and represents more costly treatment. Since the advertent of Onyx, TAE with angiographic cure has become feasible. 52, 53 Li et al 52 successfully managed 10 out of 11 cases with Onyx embolization. No signs of rebleeding or symptom progression were observed at a mean follow-up of 18.5 months.
Other DAVFs
DAVFs can also occur at other intracranial locations, including the marginal sinus, inferior and superior petrosal sinuses, major sinus wall, and hypoglossal canal. TVE by coil packing dural sinus is preferred if the affected sinus is nonfunctional and does not participate the normal venous drains. TAE by using Onyx to manage these DAVFs is indicated when the feeder is accessible.
In conclusion, endovascular management of DAVFs includes a number of options with varying risk and effectiveness for individual lesions. TAE, TVE, or direct puncture can be used depending on angioarchitecture and individual clinical scenarios. Endovascular management of DAVFs is a proven safe and effective method of treating these complex cerebrovascular lesions.
